Company intelligence / Profile preview

Omy Laboratoires

Quebec, Quebec, Canadaomycosmetics.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Omy Laboratoires has launched a commercial line of personalized dermo-cosmetic products using its proprietary AI-driven SkinAI platform. The company’s clinical claims focus on efficacy for sensitive, acne-prone, and redness-prone skin. Products are dermatologically tested and formulated with vegan ingredients; no pharmaceutical clinical trial data available.

Therapeutic areas: Dermatology
Modalities: Non-pharmacological therapy (topical skincare)Peptides (as ingredients in some products)Protein (e.g., hyaluronic acid as a protein-based ingredient)Small molecule (cosmetic actives such as plant extracts and vitamins)
Industry: Non-Drug Biotech

Partnerships

Strategic retail partnerships in North America planned or underway

Beyond the preview

Go deeper on Omy Laboratoires.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omy Laboratoires.

Explore the full profile